TD Waterhouse Canada’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,147
Closed -$116K 2343
2025
Q4
$116K Buy
1,147
+868
+311% +$69.7K ﹤0.01% 1005
2025
Q3
$15.7K Hold
279
﹤0.01% 1446
2025
Q2
$15.2K Sell
279
-30
-10% -$1.52K ﹤0.01% 1365
2025
Q1
$13.4K Buy
309
+30
+11% +$1.52K ﹤0.01% 1350
2024
Q4
$15.7K Sell
279
-4,257
-94% -$265K ﹤0.01% 1321
2024
Q3
$309K Buy
4,536
+4,207
+1,279% +$237K ﹤0.01% 699
2024
Q2
$14K Sell
329
-808
-71% -$44.5K ﹤0.01% 1294
2024
Q1
$83.8K Buy
1,137
+387
+52% +$24.5K ﹤0.01% 944
2023
Q4
$53.4K Hold
750
﹤0.01% 929
2023
Q3
$49.8K Buy
750
+200
+36% +$17K ﹤0.01% 918
2023
Q2
$51.6K Buy
+550
New +$42.9K ﹤0.01% 922

Other funds holding EXAS

TD Waterhouse Canada's EXAS Position: Q1 2026 in Review

TD Waterhouse Canada sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 1,147 shares — an estimated $116K sold.

TD Waterhouse Canada first reported a position in EXAS in Q2 2023 and held it in 11 quarters. The position peaked at $309K in Q3 2024. 6 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • TD Waterhouse Canada reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • TD Waterhouse Canada sold 1,147 Exact Sciences shares in Q1 2026, an estimated $116K.
  • TD Waterhouse Canada first reported a position in Exact Sciences in Q2 2023 and held it in 11 quarters.
  • TD Waterhouse Canada's Exact Sciences position peaked at $309K in Q3 2024.
  • 6 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on TD Waterhouse Canada's 13F filing for Q1 2026, filed 12 May 2026.